Ivy Women And Children Hospitals Profile
Key Indicators
- Authorised Capital ₹ 3.60 Cr
as on 24-10-2024
- Paid Up Capital ₹ 3.60 Cr
as on 24-10-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 24-10-2024
- Revenue 16.26%
(FY 2023)
- Profit 68.28%
(FY 2023)
- Ebitda 47.29%
(FY 2023)
- Net Worth 25.83%
(FY 2023)
- Total Assets 36.16%
(FY 2023)
About Ivy Women And Children Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.60 Cr and a paid-up capital of Rs 3.60 Cr.
The company currently has active open charges totaling ₹5.00 M.
Nanu Som, Sai Vobbilireddi, and Leela Vallemsetty serve as directors at the Company.
- CIN/LLPIN
U85190TG2016PTC112982
- Company No.
112982
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ivy Women And Children Hospitals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nanu Som  | Director | 17-Nov-2016 | Current |
| Sai Vobbilireddi | Director | 17-Nov-2016 | Current |
| Leela Vallemsetty | Director | 07-Dec-2021 | Current |
Financial Performance of Ivy Women And Children Hospitals.
Ivy Women And Children Hospitals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.26% increase. The company also saw a substantial improvement in profitability, with a 68.28% increase in profit. The company's net worth Soared by an impressive increase of 25.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ivy Women And Children Hospitals?
In 2023, Ivy Women And Children Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹0.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 May 2019 | Hdfc Bank Limited | ₹5.00 M | Open |
How Many Employees Work at Ivy Women And Children Hospitals?
Ivy Women And Children Hospitals has a workforce of 36 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ivy Women And Children Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ivy Women And Children Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
